Home » Stocks » AngioDynamics

AngioDynamics, Inc. (ANGO)

Stock Price: $8.97 USD 0.61 (7.30%)
Updated Aug 4, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 338.12M
Revenue (ttm) 264.16M
Net Income (ttm) 49.15M
Shares Out 37.69M
EPS (ttm) -4.37
PE Ratio n/a
Forward PE 1,000.00
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 4, 2020
Last Price $8.97
Previous Close $8.36
Change ($) 0.61
Change (%) 7.30%
Day's Open 8.92
Day's Range 8.68 - 9.22
Day's Volume 542,523
52-Week Range 7.48 - 20.84

More Stats

Market Cap 338.12M
Enterprise Value 325.31M
Earnings Date (est) Oct 1, 2020
Ex-Dividend Date n/a
Shares Outstanding 37.69M
Float 37.37M
EPS (basic) 1.32
EPS (diluted) -4.37
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.00%
Payout Ratio n/a
Shares Short 986,681
Short Ratio 4.33
Short % of Float 3.43%
Beta 0.70
PE Ratio n/a
Forward PE 1,000.00
P/FCF Ratio 48,303.45
PS Ratio 1.28
PB Ratio 0.72
Revenue 264.16M
Operating Income -34.50M
Net Income 49.15M
Free Cash Flow 7,000
Net Cash 12.82M
Net Cash / Share 0.34
Gross Margin 56.89%
Operating Margin -13.06%
Profit Margin 23.00%
FCF Margin 0.00%
ROA -1.23%
ROE -30.97%
ROIC 42.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 0
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

$14.00*
Low
14.0
Current: $8.97
High
14.0
Target: 14.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue271262270354357354342222216216
Revenue Growth3.43%-3.01%-23.77%-0.74%0.6%3.66%54.07%2.86%-0.13%-
Gross Profit156144144174176180169125126127
Operating Income-16.17-13.92-26.441.97-11.558.587.87-3.9111.9620.87
Net Income61.3416.345.01-43.59-3.392.35-1.21-5.188.1212.31
Shares Outstanding37.4937.0836.6236.1635.6835.1434.8225.3824.8724.58
Earnings Per Share1.640.440.14-1.21-0.090.07-0.03-0.200.320.50
EPS Growth272.73%214.29%-------36%-
Operating Cash Flow37.4441.2955.7545.2225.6924.6826.6511.6033.8739.96
Capital Expenditures-3.12-2.39-3.00-2.33-11.38-11.17-12.12-2.49-2.96-5.04
Free Cash Flow34.3238.9052.7442.8914.3013.5114.539.1130.9134.92
Cash & Equivalents22875.4148.7633.9920.0817.9123.9637.58132100
Total Debt13291.6296.321211381431431506.556.81
Net Cash / Debt95.73-16.21-47.56-86.56-118-125-119-11212593.26
Assets836705708726773799791722437424
Liabilities22216319321922826226519831.7832.58
Book Value615543515507545537526524406391
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name AngioDynamics, Inc.
Country United States
CEO James Christopher Clemmer

Stock Information

Ticker Symbol ANGO
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: ANGO
IPO Date May 27, 2004

Description

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems; IsoLoc Endorectal Balloon's; alatus vaginal balloon packing systems; and OARtrac system, which offers real-time dose data physically delivered during various cancer treatments. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.